TSX News -
Theratechnologies to Move Forward With Development of New Single Vial Formulation for EGRIFTA(R) (Tesamorelin for Injection)
MONTREAL, QUEBEC–(Marketwired – Sept. 28, 2016) – Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it will move forward with the […]